OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
May 17, 2023
The new method was developed to isolate tissue-specific EVs from the blood in addition to using a workflow to analyze their diverse multi-omics content.
May 16, 2023
The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.
May 09, 2023
According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.
March 06, 2023
The guidance is intended to build on the existing International Council for Harmonisation (ICH) quality guidance.
April 03, 2022
Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.
January 03, 2022
A new focus on speed to market creates challenges for facility design and construction.
November 11, 2021
Hovione will invest $170 million in new capacity and capabilities in Portugal, Ireland, and New Jersey
September 22, 2021
Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.
September 16, 2021
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.
August 31, 2021
USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.